Back | Next |
home / stock / etnb / etnb message board
Subject | By | Source | When |
---|---|---|---|
Oh here is a link for the Chairman | subslover | investorshub | 03/22/2023 4:46:21 PM |
TY sub. In whse & out of battery. | MiamiGent | investorshub | 03/22/2023 3:24:10 PM |
$ETNB: I concur, Sir, on ALL of your | Invest-in-America | investorshub | 03/22/2023 2:37:46 PM |
Hey, dude, it's been a while. I found | subslover | investorshub | 03/22/2023 2:12:12 PM |
$ETNB: Soaring, Boss!!! Will it hold past the | Invest-in-America | investorshub | 03/22/2023 1:53:28 PM |
What a HUGE call. Many congrats to you! | subslover | investorshub | 03/22/2023 12:24:04 PM |
$ETNB 89BIO INC | MiamiGent | investorshub | 03/20/2023 5:33:19 PM |
$15.50 | subslover | investorshub | 02/08/2023 10:13:15 PM |
$14,53 | subslover | investorshub | 02/08/2023 3:59:43 AM |
$14.45. | subslover | investorshub | 02/07/2023 2:32:30 AM |
12 dollars! | subslover | investorshub | 12/23/2022 12:58:34 AM |
89bio Announces Publication of Results of Phase 1b/2a | subslover | investorshub | 12/14/2022 8:57:18 PM |
Finally broke $9.99 after 3 weeks of flirting | subslover | investorshub | 11/12/2022 1:16:53 AM |
$10 test still comin' for us subs buddy choo-choo;) | doogdilinger | investorshub | 10/18/2022 5:30:52 PM |
Huge moe today closed $9.27 up 25% | subslover | investorshub | 10/17/2022 11:45:20 PM |
Don't know but I feel $10.00 is in | subslover | investorshub | 10/12/2022 1:05:20 AM |
Closed at $8.49 for an incredible week's gain. | subslover | investorshub | 10/08/2022 3:58:41 AM |
What happend 2003 OTC? | ollik78 | investorshub | 10/06/2022 9:42:58 PM |
I have a strong feeling that we see | subslover | investorshub | 10/06/2022 2:53:27 PM |
Yes you did brotha and man oh man | doogdilinger | investorshub | 10/06/2022 2:50:20 PM |
News, Short Squeeze, Breakout and More Instantly...
89bio Inc. Company Name:
ETNB Stock Symbol:
NYSE Market:
On Wednesday, the stocks of Madrigal Pharmaceuticals Inc (NASDAQ:MDGL) and Sagimet Biosciences Inc (NASDAQ:SGMT) are trading lower. At the EASL Int...
SAN FRANCISCO, May 22, 2024 (GLOBE NEWSWIRE) -- 89bio, Inc. (NASDAQ:ETNB), a clinical-stage biopharmaceutical company focused on the development...
SAN FRANCISCO, May 22, 2024 (GLOBE NEWSWIRE) -- 89bio, Inc. (Nasdaq: ETNB), a clinical-stage biopharmaceutical company focused on the development and commercialization of innovative therapies for the treatment of liver and cardiometabolic diseases, today announced that data from the 48-week exten...